Биостатистика, фармакокинетика и клинические исследования.

Домашняя страница
- О сайте
Материалы
- Быстрые команды R Project
- Ссылки
Инструменты
- Рандомизационный список
Блог
Контакты
Профиль

Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
Главные ошибки при формировании базы данных в MS Excel
Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
Julia:ReplicateBE – release 0.2.0
ClinicalTrialUtilities: обзор

Галерея

Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up
Source: FDA - What's New: Drugs RSS Feed Published on 2022-09-30 By FDA
CDER Small Business and Industry Assistance (SBIA) Learn
Source: FDA - What's New: Drugs RSS Feed Published on 2022-09-30 By FDA
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Source: FDA - What's New: Drugs RSS Feed Published on 2022-09-30 By FDA
FDA Approves New Treatment Option for Patients with ALS
Source: FDA - What's New: Drugs RSS Feed Published on 2022-09-30 By FDA
Afluria, Afluria Southern Hemisphere
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2022-09-29 By FDA
Q&A with FDA
Source: FDA - What's New: Drugs RSS Feed Published on 2022-09-29 By FDA
Patient Materials
Source: FDA - What's New: Drugs RSS Feed Published on 2022-09-29 By FDA
Vaccines and Related Biological Products Advisory Committee October 6, 2022 Meeting Announcement - 10/06/2022
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2022-09-29 By FDA
Curriculum Materials for Health Care Degree Programs | Biosimilars
Source: FDA - What's New: Drugs RSS Feed Published on 2022-09-29 By FDA
Industry Information and Guidance
Source: FDA - What's New: Drugs RSS Feed Published on 2022-09-29 By FDA
Adenovirus Type 4 and Type 7 Vaccine, Live, Oral
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2022-09-29 By FDA
The FDA Compounding Incidents Program: Adverse Events Associated with Compounded Drugs from Outsourcing Facilities
Source: FDA - What's New: Drugs RSS Feed Published on 2022-09-29 By FDA
The FDA Compounding Incidents Program: Adverse Events Associated with Compounded Drugs from Outsourcing Facilities | Audio Transcript
Source: FDA - What's New: Drugs RSS Feed Published on 2022-09-29 By FDA
Notable Approvals | Drugs
Source: FDA - What's New: Drugs RSS Feed Published on 2022-09-29 By FDA
FDA approves first treatment for prurigo nodularis
Source: FDA - What's New: Drugs RSS Feed Published on 2022-09-29 By FDA

Предыдущие записи

Тема: Scaffold от Danny Cooper.